[Federal Register Volume 84, Number 180 (Tuesday, September 17, 2019)]
[Notices]
[Page 48942]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20050]



[[Page 48942]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Limited Competition Cohort Studies of HIV/AIDS and 
Substance Abuse (U01 Clinical Trial Not Allowed)
    Date: October 1, 2019.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, Neuroscience Center 
Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852 
(Telephone Conference Call).
    Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
4238, MSC 9550 Bethesda, MD 20892, 301-402-6020, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; (T32) Ruth L. Kirschstein National Research Service 
Award (NRSA) Institutional Research Training Grants.
    Date: November 6-7, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center 
Building (NSC), 6001 Executive Boulevard, Rockville, MD 20852.
    Contact Person: Susan O McGuire, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., 
Room 4245, Rockville, MD 20852, 301-435-1426, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Limited Competition for Adolescent Brain Cognitive 
Development (ABCD) Study--Linked Research Project Sites 
(Collaborative U01 Clinical Trial Not Allowed).
    Date: November 8, 2019.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: Cambria Hotel Rockville, 1 Helen Heneghan Way, Rockville, 
MD 20850.
    Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, Division of 
Extramural Research, National Institute on Drug Abuse, NIH/DHHS, 
6001 Executive Blvd., Rm. 4234, Bethesda, MD 20892, 301-402-7371, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Limited Competition for Adolescent Brain Cognitive 
Development (ABCD) Study--Data Analysis, Informatics and Resource 
Center & Coordinating Center (U24 Clinical Trial Not Allowed).
    Date: November 8, 2019.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: Cambria Hotel Rockville, 1 Helen Heneghan Way, Rockville, 
MD 20850.
    Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, Division of 
Extramural Research, National Institute on Drug Abuse, NIH/DHHS, 
6001 Executive Blvd., Rm. 4234, Bethesda, MD 20892, 301-402-7371, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: September 11, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-20050 Filed 9-16-19; 8:45 am]
BILLING CODE 4140-01-P